Axogen, Inc. — Director's Dealing 2025

Dec 5, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2025-12-04

Reporting Person: DALE MICHAEL D (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-04	Common Stock	A	150000	—	Acquired	150000	Direct

Footnotes

F1: This reflects the number of shares that vested as of December 4, 2025 upon the attainment of certain performance criteria.